FI812183L - 3,1-benzoxazin-2-oner deras framstaellning och anvaendning - Google Patents

3,1-benzoxazin-2-oner deras framstaellning och anvaendning

Info

Publication number
FI812183L
FI812183L FI812183A FI812183A FI812183L FI 812183 L FI812183 L FI 812183L FI 812183 A FI812183 A FI 812183A FI 812183 A FI812183 A FI 812183A FI 812183 L FI812183 L FI 812183L
Authority
FI
Finland
Prior art keywords
group
hydrogen
alkyl
methyl
hydrogen atom
Prior art date
Application number
FI812183A
Other languages
English (en)
Other versions
FI74703B (fi
FI74703C (fi
Inventor
Anton Mentrup
Kurt Schromm
Ernst-Otto Renth
Wolfgang Hoefke
Wolfram Gaida
Ilse Streller
Armin Fygner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI812183L publication Critical patent/FI812183L/fi
Publication of FI74703B publication Critical patent/FI74703B/fi
Application granted granted Critical
Publication of FI74703C publication Critical patent/FI74703C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FI812183A 1980-07-12 1981-07-10 Foerfarande foer framstaellning av terapeutiskt verksamma 3,1-bensoxazin-2-oner. FI74703C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803026534 DE3026534A1 (de) 1980-07-12 1980-07-12 3,1-benzoxazin-2-one, ihre herstellung und verwendung
DE3026534 1980-07-12

Publications (3)

Publication Number Publication Date
FI812183L true FI812183L (fi) 1982-01-13
FI74703B FI74703B (fi) 1987-11-30
FI74703C FI74703C (fi) 1988-03-10

Family

ID=6107085

Family Applications (1)

Application Number Title Priority Date Filing Date
FI812183A FI74703C (fi) 1980-07-12 1981-07-10 Foerfarande foer framstaellning av terapeutiskt verksamma 3,1-bensoxazin-2-oner.

Country Status (25)

Country Link
US (1) US4341778A (fi)
EP (1) EP0043940B1 (fi)
JP (1) JPS5748975A (fi)
KR (1) KR850000755B1 (fi)
AT (1) ATE9336T1 (fi)
AU (1) AU540916B2 (fi)
CA (1) CA1165317A (fi)
DD (1) DD202018A5 (fi)
DE (2) DE3026534A1 (fi)
DK (1) DK149851C (fi)
ES (4) ES8205402A1 (fi)
FI (1) FI74703C (fi)
GB (1) GB2080296B (fi)
GR (1) GR74333B (fi)
HK (1) HK98286A (fi)
HU (1) HU183515B (fi)
IE (1) IE52508B1 (fi)
IL (1) IL63285A (fi)
NO (1) NO158578C (fi)
NZ (1) NZ197678A (fi)
PH (1) PH17425A (fi)
PT (1) PT73338B (fi)
SG (1) SG77686G (fi)
YU (1) YU170181A (fi)
ZA (1) ZA814687B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446319A (en) * 1981-04-28 1984-05-01 Takeda Chemical Industries, Ltd. Aminocyclitols and their production
JPS62238288A (ja) * 1986-04-04 1987-10-19 Nippon Tokushu Noyaku Seizo Kk 環状カルバメ−ト及び農園芸用殺菌剤
FR2636065B1 (fr) * 1988-09-08 1993-05-07 Fabre Sa Pierre Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
FR2680172B1 (fr) * 1991-08-05 1993-11-19 Fabre Medicament Pierre Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
CA2210138A1 (en) * 1995-01-24 1996-08-01 Peter D. Williams Tocolytic oxytocin receptor antagonists
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
DE102004003428A1 (de) 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
JPWO2006077821A1 (ja) * 2005-01-19 2008-06-19 大日本住友製薬株式会社 アルドステロン受容体調節剤としての芳香族スルホン化合物
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
WO2008023001A1 (en) * 2006-08-22 2008-02-28 Boehringer Ingelheim International Gmbh Powder formulations for inhalation containing enantiomerically pure beta-agonists
UY30550A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
PE20081358A1 (es) * 2006-08-22 2008-10-31 Boehringer Ingelheim Int Combinaciones farmacologicas para el tratamiento de enfermedades de la vias aereas
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
DD144050A5 (de) * 1978-06-05 1980-09-24 Ciba Geigy Ag Verfahren zur herstellung von n-alkylierten aminoalkoholen
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen

Also Published As

Publication number Publication date
ES8300725A1 (es) 1982-11-01
DK306781A (da) 1982-01-13
ZA814687B (en) 1983-03-30
AU540916B2 (en) 1984-12-06
IL63285A0 (en) 1981-10-30
IE52508B1 (en) 1987-11-25
SG77686G (en) 1987-02-27
PH17425A (en) 1984-08-08
DE3026534A1 (de) 1982-03-18
IL63285A (en) 1985-03-31
CA1165317A (en) 1984-04-10
FI74703B (fi) 1987-11-30
US4341778A (en) 1982-07-27
ES503837A0 (es) 1982-06-01
KR830006248A (ko) 1983-09-20
GR74333B (fi) 1984-06-25
ES508653A0 (es) 1982-11-01
EP0043940B1 (de) 1984-09-12
ES8300726A1 (es) 1982-11-01
ES508654A0 (es) 1982-11-01
ES8300727A1 (es) 1982-11-01
ATE9336T1 (de) 1984-09-15
JPS5748975A (en) 1982-03-20
NO158578C (no) 1988-10-05
NO812355L (no) 1982-01-13
ES8205402A1 (es) 1982-06-01
NZ197678A (en) 1984-12-14
YU170181A (en) 1983-10-31
HK98286A (en) 1986-12-24
FI74703C (fi) 1988-03-10
DE3166003D1 (en) 1984-10-18
GB2080296B (en) 1983-09-28
ES508655A0 (es) 1982-11-01
PT73338A (de) 1981-08-01
DD202018A5 (de) 1983-08-24
EP0043940A1 (de) 1982-01-20
IE811567L (en) 1982-01-12
NO158578B (no) 1988-06-27
HU183515B (en) 1984-05-28
DK149851C (da) 1987-05-04
KR850000755B1 (en) 1985-05-25
DK149851B (da) 1986-10-13
GB2080296A (en) 1982-02-03
AU7273181A (en) 1982-09-16
PT73338B (en) 1983-06-20

Similar Documents

Publication Publication Date Title
FI812183L (fi) 3,1-benzoxazin-2-oner deras framstaellning och anvaendning
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK422583A (da) Fremgangsmaade til fremstilling af diazobicyclo-(3,3,1)-nonaner
ATE34575T1 (de) Neue theophyllin-derivate und verfahren zu ihrer herstellung.
IL64647A (en) 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.
PT83786A (de) Neue basisch substituierte pyridinverbindungen verfahren zu ihrer herstellung die sie enthaltenden arzneimittel und ihre verwendung

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: C.H. BOEHRINGER SOHN